Track: Neuro and Radiation Oncology

Neuro and Radiation Oncology

The "Neuro and Radiation Oncology" session is made to provide an in-depth exploration of the intersection between neurological cancers and radiation-based treatments. This session aims to equip the latest advancements and challenges in the treatment of brain tumors and the application of radiation therapy in oncology. By integrating the latest research with practical clinical insights, this session will provide valuable knowledge for advancing patient care in this challenging field.

Brain Stem Tumors discussion will also cover the latest strategies in radiation therapy that offer hope for improved outcomes, despite the tumor's delicate and complex location.

Glioblastoma and Glioma segment will delve into the biology of gliomas, particularly glioblastoma, highlighting the genetic and molecular characteristics that make them so challenging to treat.

This part of the session will cover the latest research on Ependymoma, including advancements in surgical techniques and radiation therapy that are improving survival rates and quality of life for patients.

Chemotherapy and Chemobrain portion will discuss the cognitive side effects of chemotherapy in patients with brain tumors, exploring both the underlying mechanisms and strategies for prevention and management.

Radiation Therapy Techniques sub-session will cover the use of fractionated radiotherapy and its role in treating various types of brain tumors. These techniques allow for more precise targeting of tumors, reducing damage to surrounding healthy tissues.

This segment will discuss the Uses of X-rays, CT, and MRI imaging modalities in neuro-oncology, including how they are used to guide radiation therapy, assess tumor response, and detect recurrences.

Cancer Treatment and Radiotherapy discussion will include case studies and recent clinical trials that highlight the benefits and limitations of current radiotherapy techniques.

Radiobiology sub-session will also explore ongoing research aimed at enhancing the effectiveness of radiation therapy while reducing its side effects through advances in radiobiology.